Your browser is no longer supported. Please, upgrade your browser.
CDNA CareDx, Inc daily Stock Chart
CDNA [NASD]
CareDx, Inc
Index- P/E- EPS (ttm)-0.50 Insider Own2.40% Shs Outstand42.67M Perf Week2.55%
Market Cap928.07M Forward P/E53.97 EPS next Y0.40 Insider Trans-13.49% Shs Float39.02M Perf Month9.90%
Income-20.90M PEG- EPS next Q0.00 Inst Own98.30% Short Float9.44% Perf Quarter-8.11%
Sales114.80M P/S8.08 EPS this Y-279.70% Inst Trans4.29% Short Ratio4.63 Perf Half Y-43.15%
Book/sh2.30 P/B9.46 EPS next Y475.71% ROA-15.30% Target Price49.20 Perf Year-22.07%
Cash/sh0.96 P/C22.69 EPS next 5Y20.00% ROE-21.90% 52W Range18.75 - 41.27 Perf YTD-13.48%
Dividend- P/FCF- EPS past 5Y17.80% ROI-20.70% 52W High-47.30% Beta0.81
Dividend %- Quick Ratio2.00 Sales past 5Y28.20% Gross Margin62.30% 52W Low16.00% ATR1.00
Employees227 Current Ratio2.20 Sales Q/Q59.40% Oper. Margin-23.60% RSI (14)53.10 Volatility4.03% 4.83%
OptionableYes Debt/Eq0.00 EPS Q/Q92.00% Profit Margin-18.30% Rel Volume0.97 Prev Close21.87
ShortableYes LT Debt/Eq0.00 EarningsOct 31 AMC Payout- Avg Volume794.87K Price21.75
Recom1.60 SMA206.46% SMA50-5.85% SMA200-24.00% Volume767,753 Change-0.55%
Oct-01-19Resumed Craig Hallum Buy $48
May-09-19Upgrade H.C. Wainwright Neutral → Buy $30 → $43
Feb-15-19Initiated Jefferies Buy $35
Oct-23-18Resumed Raymond James Strong Buy $30
Sep-18-18Reiterated H.C. Wainwright Neutral $17 → $22
Nov-27-17Initiated H.C. Wainwright Buy $12
Jun-14-16Reiterated Mizuho Buy $12 → $8
Sep-29-15Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15Initiated Craig Hallum Buy
Mar-18-15Reiterated Mizuho Buy $15 → $12
Dec-07-19 12:26PM  Is CareDx, Inc. (CDNA) A Good Stock To Buy? Insider Monkey
Nov-19-19 07:00AM  CareDx to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-11-19 08:36AM  Did The Underlying Business Drive CareDx's (NASDAQ:CDNA) Lovely 417% Share Price Gain? Simply Wall St.
Nov-06-19 12:19PM  Edited Transcript of CDNA earnings conference call or presentation 31-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
07:00AM  CareDx at ASN Kidney Week GlobeNewswire
Nov-04-19 07:00AM  CareDx Advances Patient Care with AlloSure 3.0 GlobeNewswire -10.26%
Nov-01-19 09:00AM  All You Need to Know About CareDx (CDNA) Rating Upgrade to Strong Buy Zacks -11.90%
07:38AM  The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga
Oct-31-19 04:05PM  CareDx Reports Third Quarter 2019 Results GlobeNewswire
Oct-26-19 12:48PM  Were Hedge Funds Right About Flocking Into CareDx, Inc. (CDNA)? Insider Monkey
Oct-18-19 10:09AM  Top Ranked Momentum Stocks to Buy for October 18th Zacks
Oct-17-19 08:00AM  CareDx to Announce Third Quarter 2019 Financial Results on October 31st, 2019 GlobeNewswire
Oct-12-19 09:25AM  We're Excited To See How CareDx (NASDAQ:CDNA) Uses Its Cash Hoard To Grow Simply Wall St.
Oct-07-19 10:20AM  CareDx, Inc (CDNA) Shares March Higher, Can It Continue? Zacks
Sep-26-19 09:25AM  CareDx Files Patent Infringement Lawsuit Against Eurofins Viracor GlobeNewswire
Sep-24-19 08:00AM  CareDx Adds HistoMap To Testing Portfolio GlobeNewswire -5.60%
Sep-23-19 08:00AM  CareDxs KidneyCare iBox Technology Clinically Validated in BMJ Publication GlobeNewswire
Sep-20-19 08:00AM  CareDx Launches AlloSeq® Tx 17 at ASHI/BANFF Meeting GlobeNewswire
Sep-18-19 08:00AM  First Patient Enrolled in Landmark CareDx OKRA Registry GlobeNewswire
Sep-17-19 08:00AM  CareDx to Participate in the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-12-19 08:00AM  CareDx launches AlloSeq® cfDNA at ESOT 2019 GlobeNewswire +7.44%
07:41AM  Who Has Been Selling CareDx, Inc (NASDAQ:CDNA) Shares? Simply Wall St.
Sep-11-19 04:01PM  CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-28-19 08:00AM  CareDx Acquires XynManagement GlobeNewswire
Aug-27-19 08:00AM  Chris Cournoyer Joins CareDx Board of Directors GlobeNewswire
Aug-22-19 09:48AM  AlloSure for Heart Transplant Patients Receives CMS Draft Coverage GlobeNewswire
Aug-21-19 08:00AM  Fear of Rejection is Transplant Patients Top Concern GlobeNewswire
Aug-09-19 01:45PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc.- CDNA ACCESSWIRE -8.39%
Aug-08-19 07:16PM  Caredx Inc (CDNA) CEO Peter Maag Sold $1.4 million of Shares GuruFocus.com
Aug-05-19 09:30PM  Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. (NASDAQ: CDNA) on Behalf of Stockholders and Encourages CareDx Investors to Contact the Firm GlobeNewswire -12.40%
11:40AM  Edited Transcript of CDNA earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
06:06AM  Is CareDx, Inc's (NASDAQ:CDNA) CEO Salary Justified? Simply Wall St.
Aug-03-19 09:15AM  INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. Business Wire
Aug-02-19 01:31AM  CareDx, Inc (CDNA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-01-19 04:01PM  CareDx Reports Second Quarter 2019 Results GlobeNewswire
Jul-30-19 08:10PM  CDNA INVESTIGATION REMINDER: Hagens Berman Reminds CareDx (CDNA) Investors to Investigation of Possible Disclosure Violations ACCESSWIRE
12:32PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc. CDNA GlobeNewswire
11:44AM  CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm GlobeNewswire
Jul-26-19 05:25PM  Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group PR Newswire
Jul-25-19 10:34AM  CareDx (CDNA) Reports Next Week: Wall Street Expects Earnings Growth Zacks -5.12%
Jul-24-19 07:07PM  CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm PR Newswire
Jul-23-19 12:29PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc. CDNA GlobeNewswire
Jul-22-19 09:00PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
06:22PM  INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
Jul-17-19 09:30PM  Bragar Eagel & Squire, P.C. Is Investigating Hibbett Sports, Pintec Technology, CareDX, and Ideanomics on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
03:18PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Announces Investigation of CareDx Inc.-- CDNA PR Newswire
Jul-16-19 08:03PM  CDNA INVESTIGATION ALERT: Hagens Berman Alerts CareDx (CDNA) Investors to Investigation of Possible Disclosure Violations PR Newswire -12.91%
04:51PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
04:09PM  Here's Why CareDx Stock Is Sliding Today Motley Fool
01:51PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
Jul-11-19 08:00AM  CareDx Applauds White House Efforts to Reform Americas Kidney Health System GlobeNewswire
04:50AM  CareDx Looks Like It Can Continue Its Impressive Rally, So Go Long TheStreet.com
Jul-10-19 05:32PM  Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others Zacks
Jul-09-19 10:00AM  What You Must Know About CareDx, Inc's (NASDAQ:CDNA) Beta Value Simply Wall St. +9.01%
Jul-02-19 08:00AM  Grace Colón succeeds Amy Abernethy on the CareDx Board GlobeNewswire
Jun-27-19 08:00AM  CareDx Supports Momentum in Medicare Immunosuppressive Medication Legislation GlobeNewswire
Jun-26-19 08:00AM  US Patent Office Issues New Transplant Patent to CareDx GlobeNewswire
Jun-19-19 06:51PM  Hedge Funds Have Never Been This Bullish On CareDx, Inc. (CDNA) Insider Monkey
Jun-10-19 08:00AM  CareDx to Participate in Upcoming Conferences GlobeNewswire
Jun-03-19 01:55PM  Is CareDx, Inc (NASDAQ:CDNA) Trading At A 41% Discount? Simply Wall St.
May-29-19 08:00AM  CareDx Announces KidneyCare and Showcases Leadership in Transplantation at ATC GlobeNewswire
May-22-19 08:36AM  CareDx to Participate in Upcoming Conferences GlobeNewswire
May-16-19 07:01PM  Edited Transcript of CDNA earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-14-19 08:33AM  CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients GlobeNewswire
May-09-19 12:14PM  Here's Why CareDx Stock Is Rising Today Motley Fool +12.86%
May-08-19 09:48PM  CareDx, Inc (CDNA) Q1 2019 Earnings Call Transcript Motley Fool
06:45PM  CareDx (CDNA) Q1 Earnings and Revenues Top Estimates Zacks
05:39PM  CareDx: 1Q Earnings Snapshot Associated Press
04:01PM  CareDx Reports First Quarter 2019 Results GlobeNewswire
May-07-19 09:00AM  CareDxs AlloSeq cfDNA and QTYPE Solutions Featured at EFI 2019 GlobeNewswire -5.95%
May-06-19 07:32AM  The CareDx (NASDAQ:CDNA) Share Price Is Up 580% And Shareholders Are Delighted Simply Wall St.
May-03-19 09:25AM  Hedge Funds Have Never Been This Bullish On CareDx, Inc. (CDNA) Insider Monkey +5.92%
08:00AM  AlloMap In-Network with Anthem Blue Cross GlobeNewswire
May-02-19 08:00AM  CareDx Adds iBox Technology, Next Step Towards Artificial Intelligence in Transplant Care GlobeNewswire
May-01-19 10:33AM  CareDx (CDNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-25-19 04:01PM  CareDx Agrees to Acquire OTTR Complete Transplant Management GlobeNewswire
Apr-23-19 08:00AM  CareDx to Announce First Quarter 2019 Financial Results on May 8th, 2019 GlobeNewswire
Apr-10-19 12:08PM  Breakeven On The Horizon For CareDx, Inc (NASDAQ:CDNA) Simply Wall St.
11:15AM  CareDx Accuses Natera of False Advertising Claims That Mislead Medical Personnel and Transplant Patients GlobeNewswire
Apr-03-19 08:00AM  Cutting-Edge HeartCare and AlloMap Solutions Featured at ISHLT 2019 GlobeNewswire
Mar-26-19 05:36PM  A new lawsuit involving Stanford and Sequoia Capital highlights fights to come over cell-free DNA testing TechCrunch
09:15AM  CareDx Files Patent Infringement Lawsuit Against Natera GlobeNewswire
Mar-25-19 07:00AM  Market Trends Toward New Normal in Louisiana-Pacific, The Michaels Companies, VEREIT, CymaBay Therapeutics, CareDx, and Harsco Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Mar-13-19 08:00AM  Cedars Sinai Uses AlloSure in Tocilizumab Trial GlobeNewswire
Mar-11-19 09:17AM  These Factors Make CareDx, Inc (NASDAQ:CDNA) An Interesting Investment Simply Wall St.
08:41AM  Cisco Leads 5 Top Stocks Flexing Strength In Struggling Market Investor's Business Daily
08:00AM  AlloSure Heart Clinical Validation Published in Leading Transplant Journal GlobeNewswire
Mar-08-19 08:58AM  CareDx (CDNA) in Focus: Stock Moves 9.8% Higher Zacks
Mar-07-19 06:55PM  Edited Transcript of CDNA earnings conference call or presentation 6-Mar-19 9:30pm GMT Thomson Reuters StreetEvents +9.84%
04:53PM  Top-Rated Medical Stock Rockets After Turning A Profit A Quarter Early Investor's Business Daily
03:46PM  Here's Why CareDX Is on the Move Today Motley Fool
Mar-06-19 08:04PM  CareDx Inc (CDNA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  CareDx Reports Fourth Quarter and FY 2018 Results GlobeNewswire
Mar-05-19 08:00AM  CareDx Welcomes Initiatives from US Government to Support Transplant Care GlobeNewswire
Feb-26-19 08:00AM  CareDx to Participate in the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-21-19 08:00AM  AlloSure now available for Lung Transplant Patients GlobeNewswire
Feb-20-19 08:00AM  CareDx Drives Personalized Medicine in Transplantation at CEOT GlobeNewswire
Feb-19-19 07:45AM  Factors of Influence in 2019, Key Indicators and Opportunity within Sierra Wireless, United States Steel, CareDx, Cedar Fair, Unitil, and Cavco Industries New Research Emphasizes Economic Growth GlobeNewswire
Feb-14-19 08:00AM  CareDx to Announce Fourth Quarter 2018 Financial Results on March 6th, 2019 GlobeNewswire
Feb-13-19 07:03AM  This stock picker continues to outperform by using volatility as a friend MarketWatch
CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide. The company develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell-free DNA test initially used for kidney transplant patients. The company also develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and organs. It sells Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence-specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables speed and precision in HLA typing at a low to intermediate resolution for samples that require a fast turn-around-time and uses real-time polymerase chain reaction methodology; and TruSight HLA, a high resolution solution that uses next generation sequencing methodology. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina for the development, commercialization, and distribution of next generation sequencing product line for use in transplantation diagnostic testing. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
King SashaChief Commercial OfficerDec 09Sale21.972,12646,70848,709Dec 10 06:28 PM
HAGSTROM WILLIAM ADirectorDec 03Sale20.0612,500250,76115,385Dec 05 08:22 PM
Maag PeterChief Executive OfficerAug 06Sale28.8450,0001,441,834339,814Aug 08 04:10 PM
Cohen Fred EDirectorJul 11Option Exercise6.9615,765109,67271,279Jul 15 04:27 PM
Yee James PChief Medical OfficerJul 01Option Exercise2.3019,87545,71362,045Jul 01 09:24 PM
King SashaChief Commercial OfficerJul 01Option Exercise1.0025025057,877Jul 01 09:26 PM
King SashaChief Commercial OfficerJul 01Sale35.749,542341,04548,335Jul 01 09:26 PM
Yee James PChief Medical OfficerJul 01Sale35.6520,000712,93642,045Jul 01 09:24 PM
King SashaChief Commercial OfficerJun 20Option Exercise10.4916,195169,81688,467Jun 21 05:08 PM
Bell Michael BrianChief Financial OfficerJun 20Option Exercise10.9914,702161,59485,602Jun 21 05:07 PM
Bell Michael BrianChief Financial OfficerJun 20Sale38.8114,702570,60170,900Jun 21 05:07 PM
King SashaChief Commercial OfficerJun 20Sale38.3830,8401,183,51357,627Jun 21 05:08 PM
Yee James PChief Medical OfficerJun 17Option Exercise6.4920,000129,80062,170Jun 18 07:02 PM
Yee James PChief Medical OfficerJun 17Sale37.5420,000750,87642,170Jun 18 07:02 PM
HAGSTROM WILLIAM ADirectorJun 04Sale32.3515,000485,25025,272Jun 04 09:35 PM
Bell Michael BrianChief Financial OfficerMay 20Option Exercise3.912,2028,59979,299May 22 06:05 AM
Bell Michael BrianChief Financial OfficerMay 20Sale32.102,20270,69477,097May 22 06:05 AM
Maag PeterChief Executive OfficerMay 13Sale31.1180,0002,488,496408,406May 13 09:29 PM
Bell Michael BrianChief Financial OfficerMay 09Option Exercise3.902,2018,59391,991May 13 04:21 PM
Bell Michael BrianChief Financial OfficerMay 09Sale32.4214,894482,88477,097May 13 04:21 PM
King SashaChief Commercial OfficerMay 03Option Exercise6.041,2507,54677,844May 03 08:58 PM
King SashaChief Commercial OfficerMay 03Sale29.501,25036,87576,594May 03 08:58 PM
Maag PeterSee RemarksApr 17Option Exercise2.7650,000137,854488,406Apr 18 07:52 PM
King SashaChief Commercial OfficerApr 12Option Exercise5.1112,70764,92086,594Apr 12 07:48 PM
King SashaChief Commercial OfficerApr 12Sale29.8110,000298,06476,594Apr 12 07:48 PM
Maag PeterSee RemarksApr 12Sale29.11100,0002,910,530438,406Apr 12 07:48 PM
Maag PeterSee RemarksApr 09Option Exercise5.8380,000466,587538,406Apr 09 09:43 PM
Goldberg MichaelDirectorMar 14Sale37.3650,0001,867,82584,740Mar 14 09:25 PM
Yee James PChief Medical OfficerMar 12Sale35.187,598267,28243,409Mar 12 09:09 PM
Maag PeterSee RemarksMar 11Sale34.2350,0001,711,280458,406Mar 11 09:15 PM
Bell Michael BrianChief Financial OfficerMar 01Sale31.3613,000407,74277,290Mar 05 06:56 PM
King SashaChief Commercial OfficerFeb 22Option Exercise5.907,50044,25081,387Feb 22 09:36 PM
King SashaChief Commercial OfficerFeb 22Sale29.037,500217,72573,887Feb 22 09:36 PM
Bell Michael BrianChief Financial OfficerFeb 20Option Exercise3.982,0628,20479,260Feb 21 09:35 PM
Bell Michael BrianChief Financial OfficerFeb 20Sale26.302,20057,86077,060Feb 21 09:35 PM
King SashaChief Commercial OfficerFeb 15Option Exercise5.902,50014,75076,387Feb 19 07:34 PM
Bell Michael BrianChief Financial OfficerFeb 15Option Exercise4.4528,122125,205105,320Feb 19 07:34 PM
Bell Michael BrianChief Financial OfficerFeb 15Sale25.4028,122714,29977,198Feb 19 07:34 PM
King SashaChief Commercial OfficerFeb 15Sale25.002,50062,50073,887Feb 19 07:34 PM
Yee James PChief Medical OfficerFeb 12Option Exercise3.847,29827,99577,192Feb 13 09:38 PM
Yee James PChief Medical OfficerFeb 12Sale23.8832,500776,10044,692Feb 13 09:38 PM
Abernethy AmyDirectorJan 22Option Exercise12.885,00064,40015,837Jan 23 09:44 PM
King SashaChief Commercial OfficerJan 02Option Exercise2.804,55612,75760,932Jan 04 04:19 PM
King SashaChief Commercial OfficerDec 26Option Exercise1.662,8344,69256,376Dec 26 08:06 PM